Short Interest in Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) Rises By 400.0%

Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) was the target of a large increase in short interest in the month of March. As of March 31st, there was short interest totalling 500 shares, an increase of 400.0% from the March 15th total of 100 shares. Based on an average daily trading volume, of 2,700 shares, the days-to-cover ratio is currently 0.2 days.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Stock Performance

NASDAQ:HROWM traded down $0.45 during trading hours on Tuesday, reaching $25.90. 1,838 shares of the company were exchanged, compared to its average volume of 3,662. Harrow Health, Inc. 11.875% Senior Notes due 2027 has a twelve month low of $24.90 and a twelve month high of $27.70. The stock’s 50-day moving average is $26.57 and its 200-day moving average is $26.46.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 30th. Investors of record on Tuesday, April 15th will be paid a $0.7422 dividend. This represents a $2.97 annualized dividend and a yield of 11.46%. The ex-dividend date is Tuesday, April 15th.

About Harrow Health, Inc. 11.875% Senior Notes due 2027

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.